Novera Therapeutics Inc.

/news/oicr-uhn-novera-therapeutics-announce-collaboration-johnson-johnson-innovation-drug-discovery
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Seed
Fund:
Compass Rose
Development of BCL6 Inhibitors for Treatment of Hematological Cancers

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.